Xiaodong Zheng

Dr. Xiaodong Zheng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2021 in Frontiers in Materials
Verified
Journal Article
Open access
PDF file
MSMin Song
Min Song
Xiaogang LinXiaogang Lin
Xiaogang Lin
ZPZhijia Peng
Zhijia Peng
SXShibin Xu
Shibin Xu
LJLifeng Jin
Lifeng Jin
HLHaoyue Luo
Haoyue Luo
Biosensors can convert the concentration of biological analytes into an electrical signal or other signals for detection. They are widely used in medical diagnostics, food safety, process control, and environmental monitoring fields. In recent years, new schemes of stable biosensor interfaces have attracted much attention. Interface design is a vital part of biosensor development, since its stability can be directly related to the quality of sensing performance such as sensitivity, stability, and linearity. This review summarized the latest methods and materials used to construct stable biosensor interfaces and pointed some future perspectives and challenges of them. From the literature, we found that nanomaterials, polymers, and their composites such as chitosan, cellulose, and conducting polymers are the most common materials used in the biosensor interface design. Apart from materials, there are increasing developments in monolayer membrane techniques, three-dimensional constructions, and other interface techniques. This review is a study of the latest progress in biosensor interface stability solutions, which may provide some references and innovative directions of biosensor interface design for researchers in biosensor fields and encourage people to further explore new materials and methods.

17 August 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
KWKe Wang
Ke Wang
ZPZhijia Peng
Zhijia Peng
Xiaogang LinXiaogang Lin
Xiaogang Lin
WNWeiqi Nian
Weiqi Nian
XZXiaodong Zheng
Xiaodong Zheng
Jie Jayne WuJie Jayne Wu
Jie Jayne Wu
Early diagnosis and treatment have always been highly desired in the fight against cancer, and detection of circulating tumor DNA (ctDNA) has recently been touted as highly promising for early cancer-screening. Consequently, the detection of ctDNA in liquid biopsy is gaining much attention in the field of tumor diagnosis and treatment, which has also attracted research interest from industry. However, it is difficult to achieve low-cost, real-time, and portable measurement of ctDNA in traditional gene-detection technology. Electrochemical biosensors have become a highly promising solution to ctDNA detection due to their unique advantages such as high sensitivity, high specificity, low cost, and good portability. Therefore, this review aims to discuss the latest developments in biosensors for minimally invasive, rapid, and real-time ctDNA detection. Various ctDNA sensors are reviewed with respect to their choices of receptor probes, designs of electrodes, detection strategies, preparation of samples, and figures of merit, sorted by type of electrode surface recognition elements. The development of biosensors for the Internet of Things, point-of-care testing, big data, and big health is analyzed, with a focus on their portable, real-time, and non-destructive characteristics.

5 May 2020 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
CSChi Song
Chi Song
HLHaoyue Luo
Haoyue Luo
Xiaogang LinXiaogang Lin
Xiaogang Lin
ZPZhijia Peng
Zhijia Peng
LWLingdong Weng
Lingdong Weng
XZXiaodong Zheng
Xiaodong Zheng
In recent years, non-toxic quantum dot has caught the attention of biomedical fields. However, the inherent cytotoxicity of QDs makes its biomedical application painful, and is a major drawback of this method. In this paper, a non-toxic and water-soluble quantum dot AgInZnS-GO using graphene oxide was synthesized. A simple model of state complex was also established, which is produced through a combination of quantum dots and protein. The interaction between AIZS-GO QDs and human serum albumin (HSA) has significant meaning in vivo biological application. Herein, the binding of AIZS-GO QDs and HSA were researched using fluorescence spectra, Uv-visible absorption spectra, FT-IR spectra, and circular dichroism (CD) spectra. The results of fluorescence spectra demonstrate that AIZS-GO QDs have an obvious fluorescence quenching effect on HSA. The quenching mechanism is static quenching, which implies that some type of complex was produced by the binding of QDs and HSA. These results were further proved by Uv-visible absorption spectroscopy. The Stern-Volmer quenching constant Ksv at various temperatures (298 K, 303 K, 308 K) were acquired from analyzing Stern-Volmer plots of the fluorescence quenching information. The Van't Hoff equation could describe the thermodynamic parameters, which demonstrated that the van der Waals and hydrogen bonds had an essential effect on the interaction. FT-IR spectra and CD spectra further indicate that AIZS-GO QDs can alter the structure of HSA. These spectral methods show that the quantum dot can combine well with HSA. The experimental results showed that AgInZn-GO water-soluble quantum dots have good biocompatibility, which can be combined with proteins to form new compounds which have no cytotoxicity and biological practicability. It provides an important basis for the combination of quantum dots and specific proteins as well as fluorescent labeling.

21 October 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
ZGZhiyun Gu
Zhiyun Gu
HYHaojie Yin
Haojie Yin
HZHaiwei Zhang
Haiwei Zhang
HZHui Zhang
Hui Zhang
XLXiaoyu Liu
Xiaoyu Liu
XZXiaodong Zheng
Xiaodong Zheng
Serum exosomal microRNAs (miRNAs) are potential biomarkers for tumor diagnosis. Clinically, reverse transcription-quantitative polymerase chain reaction (RT−qPCR) can be used to determine the expression of exosomal miRNAs in the serum of breast cancer patients. The prerequisites for obtaining meaningful serum exosomal miRNA data of breast cancer patients include a suitable extraction method for exosomes and RT−qPCR data standardized by internal reference genes. However, the appropriate methods for the extraction of exosomes and the applicability of reference genes for analyzing exosomal miRNAs in breast cancer patients remain to be studied. This study compared the effects of three exosome extraction methods as well as the expression of exosomal miRNA in different initial serum amounts and at different serum states to identify the selection of the best method for serum exosome extraction. Five candidate reference genes including miR-16, miR-484, miR-1228, miR-191 and miR-423 for standardizing serum exosomal miRNAs were screened using five algorithms and were used for the quantification of serum exosomal miR-940. Significant downregulation of serum exosomal miR-940 expression in breast cancer was detected using miR-191 and miR-1228, whereas no significant down or up regulation was observed with miR-484, miR-423 and miR-16. Previous studies have shown that the expression level of miR-940 is downregulated in breast cancer tissues. The absolute quantitative results showed that miR-940 was significantly downregulated in breast cancer serum exosomes, which was consistent with the results from the analysis using miR-191 or miR-1228 as reference genes. Therefore, miR-191 and miR-1228 could serve as reference genes for the relative quantification of serum exosomal miRNAs. This finding indicated the importance of rigorously evaluating the stability of reference genes and standardization for serum exosomal miRNA expression. Moreover, the level of serum exosomal miR-940 in breast cancer could reflect the presence of lymph node metastasis and the status of HER2/neu, which indicates its potential as a biomarker for breast cancer metastasis. In summary, an optimized protocol for the detection of serum exosomal miR-940 as a breast cancer marker was preliminarily established.

29 April 2020 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
HLHaoyue Luo
Haoyue Luo
Xiaogang LinXiaogang Lin
Xiaogang Lin
ZPZhijia Peng
Zhijia Peng
YZYong Zhou
Yong Zhou
SXShibin Xu
Shibin Xu
XZXiaodong Zheng
Xiaodong Zheng
Nitrite is a toxic substance, when excessive nitrite enters the human body, it will be seriously harmful to human. At present, the detection methods of nitrite are complicated to operate and require expensive detection instruments. Therefore, an effective, fast and highly selective nanogold film interdigital electrode sensors that can detect nitrite easily and quickly is developed in the work. Firstly, the variation of the sensitivity of nanogold film nitrite sensors with concentrations (1 mol/L, 10−1 mol/L, 10−2 mol/L, 10−3 mol/L, 10−4 mol/L, and 10−5 mol/L) was measured by experiments. Then, Chrome-black T was modified to the surface of the nanogold film interdigital electrodes by electrochemical polymerization, and the film of chrome-black T had affinity for nitrite ions, so nitrite ions were enriched on the sensor surface. The change law of the impedance signal of the modified nanogold film nitrite sensors after being added to different concentrations of sodium nitrite solution were also concluded. The study demonstrates that the larger the concentration of sodium nitrite solution is added to the modified interdigital electrodes, the smaller impedance and resistance of the modified interdigital electrodes are reflected. Finally, specificity of the modified interdigital electrode sensors has been demonstrated. The novel interdigital electrode sensors can detect the concentration of nitrite solution conveniently and quickly with only 30 s. Therefore, the prospect of applying the novel nanogold film interdigital electrode sensors to the detection of nitrite in blood, body fluid, food and drinking water is promising.

23 May 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
CCChunrong Chen
Chunrong Chen
QXQianjie Xu
Qianjie Xu
TWTao Wang
Tao Wang
YYYuliang Yuan
Yuliang Yuan
ZHZuhai Hu
Zuhai Hu
HLHaike Lei
Haike Lei
Background: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides comprehensive data on liver cancer burden worldwide. This study aims to analyze and compare the trends in liver cancer burden in China and globally between 1990 and 2021.Methods: Data were extracted from the GBD 2021 database, which includes incidence, prevalence, mortality, and disability-adjusted life years (DALYs) for liver cancer in 204 countries and territories. Age-standardized rates (ASIR, ASPR, ASMR, ASDR) and crude rates (CIR, CPR, CMR, CDR) were calculated. Joinpoint regression analysis was used to determine the average annual percentage change (AAPC) in liver cancer burden trends.Results: In China, the number of liver cancer cases increased from 96,434 in 1990 to 196,637 in 2021, while the age-standardized incidence rate (ASIR) decreased. Globally, cases increased from 244,689 to 529,202, with a slight increase in ASIR. The age-standardized prevalence rate (ASPR) in China remained stable, while globally it increased. Age-standardized mortality rates (ASMR) and age-standardized DALY rates (ASDR) decreased in both China and globally. Males had higher rates than females in all age groups. The peak age for liver cancer burden occurred earlier in Chinese males compared to the global average.Conclusion: The liver cancer burden in China has declined over the past three decades, with a more significant decrease in China than globally. However, China still faces a higher burden compared to the global average. The earlier peak in liver cancer burden among Chinese males suggests the need for targeted prevention and control measures, especially in light of the impact of risk factors like hepatitis B and C, alcohol consumption, drug abuse, obesity, diabetes and tobacco use. Globally, liver cancer remains a significant public health challenge with rising incidence and prevalence rates, emphasizing the need for a comprehensive global approach to liver cancer prevention.